Sequential Nephron Blockade for Diuretic Resistance — SCE Palliative Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Sequential nephron blockade—add metolazone 2.5 mg OD (thiazide‑like diuretic acting at distal convoluted tubule) to existing loop diuretic
The correct answer is E. Diuretic resistance in advanced heart failure often reflects the ‘braking phenomenon’, with compensatory sodium reabsorption in the distal convoluted tubule reducing loop diuretic efficacy. Sequential nephron blockade by adding a thiazide‑like diuretic such as metolazone at low dose effectively restores diuresis even in renal dysfunction and is supported by cohort studies in ADHF with renal impairment. NICE CG187 recognises this approach as promising in resistant cases, although high-level RCT data are limited. Option C risks toxicity without overcoming the resistance mechanism. Option D acts at the same segment and lacks synergy. Option A (mannitol) is inappropriate in heart failure and renal decline. Option B abandons medical management and is dangerous without symptom-directed justification.
Reference: NICE CG187 'Acute heart failure: diagnosis and management' (2014, last reviewed 2021) and Moranville et al., 'Comparison of metolazone versus chlorothiazide in ADHF with diuretic resistance', Cardiovasc Ther 2015. https://www.nice.org.uk/guidance/cg187/chapter/recommendations